IMVT
Immunovant, Inc. · Healthcare
Chief Medical Officer William L. Macias sold $85K of Immunovant, Inc.
Sold$85,334
$25.45Price
3,353Shares
−1%Stake
What IMVT did after the filing
- The stock from Fri, Nov 22 close, $26.87
- −12.1%
- S&P 500, same days
- −0.7%
Measured over 30 trading days, to the Jan 8 close.
Traded Wed, Nov 20. Filed Fri, Nov 22, 11:11 AM ET, during the session. Returns use the Nov 22 close and the Jan 8 close. Not investment advice.